OBJECTIVE: Thrombin, a serine protease, plays an important role in thrombosis as well as other cellular and developmental processes. In this study, we investigated the ability of a novel thrombin-activatable molecular probe to provide in vivo images of thrombin activity in experimental thrombi. METHODS AND RESULTS: The thrombin probe consists of a near-infrared (NIR) fluorochrome attached to a delivery vehicle via a thrombin-specific oligopeptide substrate. In human blood, endogenous thrombin activated the thrombin probe and increased the fluorescence signal by 18-fold (P=0.008). Hirudin, a specific thrombin inhibitor, suppressed probe activation by 82% (P=0.007). Imaging of in vivo thrombin activity was then investigated in acute experimental murine thrombosis models up to 12 hours. After systemic thrombin probe injection, focal NIR fluorescence signal enhancement was rapidly detected within acute and subacute thrombi. In contrast, no thrombosis signal enhancement was seen in similar experiments with a control NIR fluorochrome. CONCLUSIONS: Thrombin activity can be imaged in vivo by using a novel thrombin-activatable and thrombin-specific NIR molecular probe. The thrombin probe could enhance the understanding of the role of thrombin in thrombogenesis and other homeostatic and pathological conditions.
OBJECTIVE:Thrombin, a serine protease, plays an important role in thrombosis as well as other cellular and developmental processes. In this study, we investigated the ability of a novel thrombin-activatable molecular probe to provide in vivo images of thrombin activity in experimental thrombi. METHODS AND RESULTS: The thrombin probe consists of a near-infrared (NIR) fluorochrome attached to a delivery vehicle via a thrombin-specific oligopeptide substrate. In human blood, endogenous thrombin activated the thrombin probe and increased the fluorescence signal by 18-fold (P=0.008). Hirudin, a specific thrombin inhibitor, suppressed probe activation by 82% (P=0.007). Imaging of in vivo thrombin activity was then investigated in acute experimental murinethrombosis models up to 12 hours. After systemic thrombin probe injection, focal NIR fluorescence signal enhancement was rapidly detected within acute and subacute thrombi. In contrast, no thrombosis signal enhancement was seen in similar experiments with a control NIR fluorochrome. CONCLUSIONS:Thrombin activity can be imaged in vivo by using a novel thrombin-activatable and thrombin-specific NIR molecular probe. The thrombin probe could enhance the understanding of the role of thrombin in thrombogenesis and other homeostatic and pathological conditions.
Authors: Emilia S Olson; Michael A Whitney; Beth Friedman; Todd A Aguilera; Jessica L Crisp; Fred M Baik; Tao Jiang; Stephen M Baird; Sotirios Tsimikas; Roger Y Tsien; Quyen T Nguyen Journal: Integr Biol (Camb) Date: 2012-04-26 Impact factor: 2.192
Authors: Robert Flaumenhaft; Eiichi Tanaka; Gwenda J Graham; Alec M De Grand; Rita G Laurence; Kozo Hoshino; Roger J Hajjar; John V Frangioni Journal: Circulation Date: 2006-12-18 Impact factor: 29.690
Authors: Hassan Albadawi; Avery A Witting; Yash Pershad; Alex Wallace; Andrew R Fleck; Peter Hoang; Ali Khademhosseini; Rahmi Oklu Journal: Cardiovasc Diagn Ther Date: 2017-12
Authors: Shanta M Messerli; Shilpa Prabhakar; Yi Tang; Khalid Shah; Maria L Cortes; Vidya Murthy; Ralph Weissleder; Xandra O Breakefield; Ching-Hsuan Tung Journal: Neoplasia Date: 2004 Mar-Apr Impact factor: 5.715
Authors: Beth Friedman; Michael A Whitney; Elamprakash N Savariar; Christa Caneda; Paul Steinbach; Qing Xiong; Dina V Hingorani; Jessica Crisp; Stephen R Adams; Michael Kenner; Csilla N Lippert; Quyen T Nguyen; Monica Guma; Roger Y Tsien; Maripat Corr Journal: Arthritis Rheumatol Date: 2017-11-29 Impact factor: 10.995
Authors: Jason R McCarthy; Purvish Patel; Ion Botnaru; Pouneh Haghayeghi; Ralph Weissleder; Farouc A Jaffer Journal: Bioconjug Chem Date: 2009-06 Impact factor: 4.774